Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura.

@article{Stasi2002VariablePO,
  title={Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura.},
  author={Roberto Stasi and Elisa Stipa and Vittorio Forte and Paola Meo and Sergio Amadori},
  journal={Blood},
  year={2002},
  volume={99 10},
  pages={
          3872-3
        }
}
In a recent issue of Blood we reported that rituximab anti-CD20 monoclonal antibody is an active drug in adults with chronic idiopathic thrombocytopenic purpura (ITP), that it is able to induce long-lasting responses, and that in all responders a rise of the platelet count occurs early during 

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 54 CITATIONS, ESTIMATED 43% COVERAGE

Rituximab in the treatment of relapsing idiopathic thrombocytopenic purpura.

  • The Netherlands journal of medicine
  • 2003
VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Rituximab in the treatment of autoimmune haematological disorders

St Michael’s
  • 2008
VIEW 5 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Efficiency of treatment with rituximab in platelet transfusion refractoriness: a study of 7 cases.

  • International journal of clinical and experimental medicine
  • 2015
VIEW 3 EXCERPTS
CITES RESULTS

FILTER CITATIONS BY YEAR

2003
2018

CITATION STATISTICS

  • 4 Highly Influenced Citations